- Home
- ALDX vs MTLS Comparison
ALDX vs MTLS Comparison
Compare ALDX & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- MTLS
- Stock Information
- Founded
- ALDX 2004
- MTLS 1990
- Country
- ALDX United States
- MTLS Belgium
- Employees
- ALDX N/A
- MTLS N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- MTLS Computer Software: Prepackaged Software
- Sector
- ALDX Health Care
- MTLS Technology
- Exchange
- ALDX Nasdaq
- MTLS Nasdaq
- Market Cap
- ALDX 342.3M
- MTLS 349.7M
- IPO Year
- ALDX 2014
- MTLS 2014
- Fundamental
- Price
- ALDX $5.39
- MTLS $5.11
- Analyst Decision
- ALDX Strong Buy
- MTLS
- Analyst Count
- ALDX 2
- MTLS 0
- Target Price
- ALDX $9.50
- MTLS N/A
- AVG Volume (30 Days)
- ALDX 772.4K
- MTLS 124.5K
- Earning Date
- ALDX 11-06-2025
- MTLS 10-23-2025
- Dividend Yield
- ALDX N/A
- MTLS N/A
- EPS Growth
- ALDX N/A
- MTLS N/A
- EPS
- ALDX N/A
- MTLS 0.11
- Revenue
- ALDX N/A
- MTLS $311,850,851.00
- Revenue This Year
- ALDX N/A
- MTLS $2.98
- Revenue Next Year
- ALDX $43.00
- MTLS $7.09
- P/E Ratio
- ALDX N/A
- MTLS $49.16
- Revenue Growth
- ALDX N/A
- MTLS 2.98
- 52 Week Low
- ALDX $1.14
- MTLS $3.93
- 52 Week High
- ALDX $7.20
- MTLS $9.69
- Technical
- Relative Strength Index (RSI)
- ALDX 45.98
- MTLS 48.70
- Support Level
- ALDX $5.48
- MTLS $4.93
- Resistance Level
- ALDX $5.88
- MTLS $5.24
- Average True Range (ATR)
- ALDX 0.27
- MTLS 0.18
- MACD
- ALDX -0.07
- MTLS 0.03
- Stochastic Oscillator
- ALDX 1.87
- MTLS 44.68
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.